Am J Physiol Cell Physiol AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 295: C1510-C1517, 2008. First published October 8, 2008; doi:10.1152/ajpcell.00252.2008
0363-6143/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/C1510    most recent
00252.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamawaki, H.
Right arrow Articles by Hara, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamawaki, H.
Right arrow Articles by Hara, Y.

VASCULAR BIOLOGY

Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells

Hideyuki Yamawaki, Kazuaki Saito, Muneyoshi Okada, and Yukio Hara

Department of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Towada, Aomori, Japan

Submitted 13 May 2008 ; accepted in final form 1 October 2008

Methylglyoxal (MGO) is a reactive metabolite of glucose. Since the plasma concentration of MGO is increased in diabetic patients, MGO is implicated in diabetes-associated vascular endothelial cells (ECs) injury, which might be responsible for atherosclerosis. In the present study, we examined effects of treatment of human umbilical vein ECs with MGO on EC morphology and inflammatory responses. MGO (24 h) induced cytotoxic morphological changes in a concentration-dependent manner (0–420 µM). MGO induced mRNA and protein expression of cyclooxygenase (COX)-2 in a concentration (0–420 µM)- and time (6–24 h)-dependent manner. COX-2 induction was associated with increased PGE2 release. Acute treatment with MGO (20 min) induced concentration-dependent (0–420 µM) activation of JNK and p38 MAP kinase but not ERK or NF-{kappa}B. Both the JNK inhibitor SP600125 and the p38 inhibitor SB203580 prevented the MGO induction of COX-2. However, inhibiting JNK and p38 or COX-2 was ineffective to the morphological damage by MGO (420 µM, 24 h). EUK134, a synthetic combined superoxide dismutase/catalase mimetic, had no effect on MGO-induced COX-2. Present results indicated that MGO mediates JNK- and p38-dependent EC inflammatory responses, which might be independent of oxidative stress. On the other hand, MGO-induced morphological cell damage seems unlikely to be associated with COX-2-PGE2.

diabetes; vascular endothelium; inflammation; signal transduction; mitogen-activated protein kinase



Address for reprint requests and other correspondence: H. Yamawaki, Dept. of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato Univ., Towada, Aomori 034-8628, Japan (e-mail: yamawaki{at}vmas.kitasato-u.ac.jp)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.